Select Page

Anti-Human OX40L (Oxelumab) – Dylight® 488 – 100 µg

100 μg



ApplicationFA, FC
ConjugateDyLight® 488
IsotypeHuman IgG1κ
ImmunogenOriginal antibody raised against Human OX40L
Species ReactivityHuman
FormulationThis DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Research AreaCancer, Immunology
Description/BackgroundOxelumab is a human monoclonal antibody designed for the treatment of autoimmune diseases.3 Oxelumab recognizes human OX40L (TNFSF4). OX40L is a member of the tumor necrosis family and is the ligand for OX40 . The OX40/OX40L interaction generates an optimal T cell response and plays a significant role in determining the amount of memory T-cells remaining after the immune response.1 Therapeutic treatments with antibodies against TNFSF can sometimes result in serious side effects.2 More research is needed to understand the precise molecular mechanism of TNF inhibition. This cost-effective, research-grade Anti-Human OX40L (Oxelumab) utilizes the same variable regions from the therapeutic antibody Oxelumab making it ideal for research projects.
Storage TemperatureThis DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze.
ProtocolsFA, FC
Clone NumberR4930
Concentration0.2 mg/ml
Regulatory StatementFor Research Use Only. Not for use in diagnostic procedures.
100 μg